PARATEK PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
PARATEK PHARMACEUTICALS INC. - More news...
PARATEK PHARMACEUTICALS INC. - More news...
- Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital
- Investor Alert: Abbott Cooper PLLC Announces Investigation into Paratek Pharmaceuticals, Inc.; Urges Paratek Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Acquisition of Paratek Pharmaceuticals, Inc. by Gurnet Point Capital
- NexPoint Sends Demand Letter for Books and Records to Paratek Pharmaceuticals in Connection with Proposed Acquisition by Gurnet Point Capital
- NexPoint Asset Management Sends Open Letter to the Board of Paratek Pharmaceuticals Regarding Upcoming Annual Meeting and Proposed Acquisition by Gurnet Point Capital
- PRTK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paratek Pharmaceuticals, Inc. Is Fair to Shareholders
- Shareholder Alert: Ademi LLP investigates whether Paratek Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Gurnet Point Capital and Novo Holdings
- Thinking about buying stock in Geron Corp, Ashford Hospitality Trust, Paratek Pharmaceuticals, Seanergy Maritime, or TAL Education?
- Paratek Pharmaceuticals, Inc. - PRTK Stock Chart Technical Analysis for 11-05-2019
- Paratek Pharmaceuticals, Inc. - PRTK Stock Chart Technical Analysis for 08-07-2019
- Investor Expectations to Drive Momentum within Paratek Pharmaceuticals, Dell Technologies, Dover, Black Hills, Kinder Morgan, and Novo Nordisk A/S — Discovering Underlying Factors of Influence
- Paratek Pharmaceuticals, Inc. - PRTK Stock Chart Technical Analysis for 10-04-18
- Paratek Pharmaceuticals Inc to Host Earnings Call
- Investor Network: Paratek Pharmaceuticals Inc. to Host Earnings Call
- Investor Network: Paratek Pharmaceuticals Inc to Host Earnings Call
- Paratek Announces Completion of Enrollment in Omadacycline Phase 3 Community-Acquired Bacterial Pneumonia Study
- Paratek Pharmaceuticals Announces Promotion of Evan Loh, M.D. to the role of President and Chief Operating Officer
- Paratek Advances Timing of Top-Line Data for Phase 3 Community Acquired Bacterial Pneumonia Study to the Second Quarter of 2017
- Paratek Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results and Provides Clinical Updates
- Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016
- Paratek Pharmaceuticals to Report Third Quarter 2016 Financial Results and Provide Update on Clinical Progress on November 2, 2016
- Paratek, U.S. Department of Defense Enter Research Agreement to Study Omadacycline Against Biodefense Pathogens
- Paratek to Ring Nasdaq Closing Bell Recognizing 20th Anniversary